OBJECTIVES: We conducted a serological survey for Q-fever among febrile patients in Bamako and Mopti (Mali) and investigated the main risk factors for seroconversion. METHODS: Blood samples from 156 febrile patients were collected in healthcare facilities of Bamako and Mopti and examined with the microimmunofluorescence test. RESULTS: Forty per cent (n = 63) were seropositive for Q-fever, 28% in Bamako and 51% in Mopti. A more recent infection was suspected in 9.5% (n = 6) of all seropositive patients. This is the first time that Q-fever seropositivity is reported in febrile individuals in Mali. The patients' symptoms and diagnoses spanned a wide range of conditions; none had been diagnosed with Q fever by their treating physician. No risk factors for seropositivity could be identified with the exception of the city of residence and none could be identified with a logistic regression model with 'city' taken as random effect. CONCLUSION: A high rate of seropositivity to C. burnetii was found among febrile urban patients in Mali but no risk factors for seropositivity could be identified in this study.
OBJECTIVES: We conducted a serological survey for Q-fever among febrile patients in Bamako and Mopti (Mali) and investigated the main risk factors for seroconversion. METHODS: Blood samples from 156 febrile patients were collected in healthcare facilities of Bamako and Mopti and examined with the microimmunofluorescence test. RESULTS: Forty per cent (n = 63) were seropositive for Q-fever, 28% in Bamako and 51% in Mopti. A more recent infection was suspected in 9.5% (n = 6) of all seropositive patients. This is the first time that Q-fever seropositivity is reported in febrile individuals in Mali. The patients' symptoms and diagnoses spanned a wide range of conditions; none had been diagnosed with Q fever by their treating physician. No risk factors for seropositivity could be identified with the exception of the city of residence and none could be identified with a logistic regression model with 'city' taken as random effect. CONCLUSION: A high rate of seropositivity to C. burnetii was found among febrile urban patients in Mali but no risk factors for seropositivity could be identified in this study.
Authors: Malavika Prabhu; William L Nicholson; Aubree J Roche; Gilbert J Kersh; Kelly A Fitzpatrick; Lindsay D Oliver; Robert F Massung; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; John A Crump Journal: Clin Infect Dis Date: 2011-08 Impact factor: 9.079
Authors: S Dürr; B Bonfoh; E Schelling; J Kasymbekov; M G Doherr; N Toktobaev; T Schueth; J Zinsstag Journal: Rev Sci Tech Date: 2013-12 Impact factor: 1.181
Authors: Mahamoudou Touré; Pelle T Petersen; Sidy N'd Bathily; Daouda Sanogo; Christian W Wang; Karin L Schiøler; Flemming Konradsen; Seydou Doumbia; Michael Alifrangis Journal: Am J Trop Med Hyg Date: 2016-11-07 Impact factor: 2.345
Authors: Balako Gumi; Rebuma Firdessa; Lawrence Yamuah; Teshale Sori; Tadele Tolosa; Abraham Aseffa; Jakob Zinsstag; Esther Schelling Journal: J Vet Sci Med Diagn Date: 2013-03-22
Authors: Anna S Dean; Bassirou Bonfoh; Abalo E Kulo; G Aboudou Boukaya; Moussa Amidou; Jan Hattendorf; Paola Pilo; Esther Schelling Journal: PLoS One Date: 2013-08-12 Impact factor: 3.240
Authors: Julian T Hertz; O Michael Munishi; Joanne P Sharp; Elizabeth A Reddy; John A Crump Journal: Trop Med Int Health Date: 2013-09-17 Impact factor: 2.622
Authors: Francesca Scolamacchia; Ian G Handel; Eric M Fèvre; Kenton L Morgan; Vincent N Tanya; Barend M de C Bronsvoort Journal: PLoS One Date: 2010-01-21 Impact factor: 3.240